Boston Scientificvs.Edwards Lifesciences
BSX vs EW · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Boston Scientific is about 1.3× larger than Edwards Lifesciences by market cap; Boston Scientific trades at the lower P/E (18.7 vs 48.0); year to date, Edwards Lifesciences leads (+8.2% vs −53.0%).
Side by side
| BSX | EW | |
|---|---|---|
| Market cap | $66.5B | $52.6B |
| Price | $44.77 | $92.21 |
| Today | −0.5% | +1.0% |
| Return YTD | −53.0% | +8.2% |
| Return 1Y | −56.9% | +17.0% |
| P/E | 18.7 | 48.0 |
| P/S | 3.2 | 8.3 |
| P/B | 2.6 | 5.1 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →Edwards LifesciencesEW
American specialist in heart valves and structural heart treatment — including transcatheter aortic valves (TAVR).
Full EW profile →More comparisons in Medtech & devices
See where BSX and EW sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →